


Healthcare Industry News: HIV/AIDS
News Release - November 29, 2013
New Data Show Efficacy, Safety and Tolerability of Xeplion(R) in Patients with Schizophrenia at Various Stages of the Disease
Source: Janssen Pharmaceutica
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
